Bart Sanders

Bart Sanders has a varied work experience. From 2010 to 2011, they were an Intern at the University of Pennsylvania. From 2011 to 2017, they were a PhD Candidate and Postdoc at the Technische Universiteit Eindhoven. In 2017, they became the CEO and Co-Founder of STENTiT. In 2022, they became a Commission Member RvdT for the Sociaal-Economische Raad (SER), an AcTI Young Innovator for the Netherlands Academy of Technology and Innovation AcTI, and a Programme Council for the Smart BioMaterials Consortium (SBMC).

Bart Sanders received their Doctor (dr) in Biomedical Engineering from Eindhoven University of Technology in 2016. Prior to that, they obtained their Master of Science in Biomedical Engineering from Eindhoven University of Technology in 2011.